首页> 外文期刊>Circulation. Arrhythmia and electrophysiology >Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation.
【24h】

Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation.

机译:与房颤相关的钠通道β1和β2亚基的突变。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: We and others have reported mutations in the cardiac predominant sodium channel gene SCN5A in patients with atrial fibrillation (AF). We also have reported that SCN1B is associated with Brugada syndrome and isolated cardiac conduction disease. We tested the hypothesis that mutations in the 4 sodium channel beta-subunit genes SCN1B-SCN4B contribute to AF susceptibility. METHODS AND RESULTS: Screening for mutations in the 4 beta-subunit genes was performed in 480 patients with AF (118 patients with lone AF and 362 patients with AF and cardiovascular disease) and 548 control subjects (188 ethnically defined anonymized subjects and 360 subjects without AF). The effects of mutant beta-subunits on SCN5A mediated currents were studied using electrophysiological studies. We identified 2 nonsynonymous variants in SCN1B (resulting in R85H, D153N) and 2 in SCN2B (R28Q, R28W) in patients with AF. These occur at residues highly conserved across mammals and were absent in control subjects. In 3 of 4 mutation carriers, the ECGs showed saddleback-type ST-segment elevation in the right precordial leads. Transcripts encoding both SCN1B and SCN2B were detected in human atrium and ventricle. In heterologous expression studies using Chinese hamster ovary cells, the mutant beta1- or beta2-subunits reduced SCN5A-mediated current and altered channel gating compared with coexpression of wild-type subunits. CONCLUSIONS: Loss of function mutations in sodium channel beta-subunits were identified in patients with AF and were associated with a distinctive ECG phenotype. These findings further support the hypothesis that decreased sodium current enhances AF susceptibility.
机译:背景:我们和其他人已经报告了房颤(AF)患者心脏主要钠通道基因SCN5A的突变。我们还报道了SCN1B与Brugada综合征和孤立的心脏传导疾病有关。我们测试了4个钠通道β亚基基因SCN1B-SCN4B中的突变有助于AF敏感性的假说。方法和结果:对480例房颤患者(118例单发房颤患者和362例房颤和心血管疾病患者)和548例对照受试者(188名种族定义的匿名受试者和360例无房颤的受试者)进行了4个β亚基基因突变的筛查。 AF)。使用电生理学研究突变体β亚基对SCN5A介导的电流的影响。我们在患有AF的患者中发现了SCN1B中的2个非同义变体(导致R85H,D153N)和SCN2B中的2个同义变体(R28Q,R28W)。这些发生在哺乳动物之间高度保守的残基上,而在对照对象中不存在。在4个突变携带者中的3个中,ECG在右心前导联中显示鞍背型ST段抬高。在人心房和心室中检测到编码SCN1B和SCN2B的转录物。在使用中国仓鼠卵巢细胞的异源表达研究中,与野生型亚基的共表达相比,突变的β1或β2亚基减少了SCN5A介导的电流并改变了通道门控。结论:房颤患者发现钠通道β亚基功能突变丢失,并且与独特的ECG表型有关。这些发现进一步支持了钠电流减少会增强房颤敏感性的假说。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号